Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Neuroskin Forte for Dry Skin Relief in Eczema and Psoriasis

This study has been completed.
AVVAA World Healthcare Products, Inc.
Information provided by (Responsible Party):
Rutgers, The State University of New Jersey ( University of Medicine and Dentistry of New Jersey ) Identifier:
First received: August 31, 2005
Last updated: February 2, 2015
Last verified: February 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2010
  Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)